Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration.
McGowan A, Gennemark P, Akieh-Pirkanniemi M, Wirman L, Davies N, Elebring M, Tivesten A, Strimfors M, Hölttä M, Söderberg M, Berntsson V, Balas D, Koskinen M, Leino L, Abrahmsén-Alami S.
McGowan A, et al. Among authors: balas d.
Mol Pharm. 2024 Jan 1;21(1):143-151. doi: 10.1021/acs.molpharmaceut.3c00663. Epub 2023 Dec 21.
Mol Pharm. 2024.
PMID: 38126776